Trial intelligence / Profile preview

Moxifloxacin vs Ofloxacin + Metronidazole in Uncomplicated PID

NCT01799356Phase 4Completed

Start
Jun 2010
Primary completion
Mar 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of moxifloxacin in pelvic inflammatory disease (PID). Started Jun 2010; status: completed.

02

Drugs

moxifloxacin
03

Conditions

pelvic inflammatory disease (PID)

Beyond the preview

Go deeper on NCT01799356.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01799356.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call